Two obesity medicine societies and an advocacy group have teamed up to produce US-specific evidence-based guidance on obesity ...

A groundbreaking study has revealed how obesity drug Mounjaro affects brain signals linked to cravings. Researchers observed ...

A rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as Mounjaro and Zepbound, revealed that the medication suppresses signaling in the ...

Research reveals Eli Lilly's GLP-1 drug, tirzepatide, temporarily suppresses food cravings in a patient's brain reward center. While initial effects were promising, the impact faded over time. Results ...

The drugmaker said Monday that it has started selling higher doses of the injectable obesity treatment for $349 a month to ...

A rare intracranial brain-recording study revealed that tirzepatide, a GLP-1 and GIP receptor agonist, temporarily silences craving-related neural activity in a key reward circuit of the brain.

Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 ...

The popular weight loss jab Mounjaro may help to cut food cravings by suppressing brain signals that are linked to eating ...

Researchers have identified a neural biomarker of compulsive food cravings, and showed that it is suppressed by the ...

Popular drugs for diabetes and weight loss, like Ozempic, Wegovy, and Mounjaro, can have profound impacts on the body, but what about the brain? These medicines are thought to broadly suppress ...

The weight loss drug Mounjaro could curb food cravings by suppressing brain signals linked to eating control, a pioneering US ...